pmjТихоокеанский медицинский журналPacific Medical Journal1609-1175TGMU10.17238/PmJ1609-1175.2019.3.18-23pmj-319Research ArticleОБЗОРЫREVIEWSРоль штаммов Acinetobacter baumannii в развитии гнойно-септических осложнений при ожоговой травмеTHE ROLE OF ACINETOBACTER BAUMANNII STRAINS IN THE DEVELOPMENT OF SEPTIC COMPLICATIONS IN CASE OF BURN INJURYФомичеваТ. Д.FomichevaT. D.

ассистент кафедры эпидемиологии и военной эпидемиологии 

690002, г. Владивосток, пр-т Острякова, 2

2 Ostryakova Ave. Vladivostok 90002 Russian Federation

fom-anton@mail.ruСкурихинаЮ. Е.SkurikhinaYu. E.

канд. мед. наук, доцент кафедры эпидемиологии и военной эпидемиологии 

690002, г. Владивосток, пр-т Острякова, 2

2 Ostryakova Ave. Vladivostok 90002 Russian Federation

eesku@mail.ruСотниченкоС. А.SotnichenkoS. A.

д-р мед. наук, руководитель Дальневосточного окружного медицинского центра 

690000, г. Владивосток, пр-т 100 лет Владивостоку, 161

161 100 Years of Vladivostok Ave. Vladivostok 690000 Russian Federation

inbox@dvomc.vtc.ruГрибаньП. А.GribanP. A.

врач-хирург ожогового отделения стационара 

690000, г. Владивосток, пр-т 100 лет Владивостоку, 161

161 100 Years of Vladivostok Ave. Vladivostok 690000 Russian Federation

oomp@dvomc.vtc.ruФедорецВ. В.FedoretsV. V.

клинический ординатор кафедры эпидемиологии и военной эпидемиологии 

690002, г. Владивосток, пр-т Острякова, 2

2 Ostryakova Ave. Vladivostok 90002 Russian Federation

kaf.epi.vladmed@mail.ruТимошенкоМ. В.TymoshenkoM. V.

клинический ординатор кафедры эпидемиологии и военной эпидемиологии 

690002, г. Владивосток, пр-т Острякова, 2

2 Ostryakova Ave. Vladivostok 90002 Russian Federation

kaf.epi.vladmed@mail.ruАйвазянР. Р.AyvazianR. R.

клинический ординатор кафедры эпидемиологии и военной эпидемиологии

690002, г. Владивосток, пр-т Острякова, 2

2 Ostryakova Ave. Vladivostok 90002 Russian Federation

kaf.epi.vladmed@mail.ruТихоокеанский государственный медицинский университетРоссияPacific State Medical UniversityRussian FederationТихоокеанский государственный медицинский университет,РоссияPacific State Medical UniversityRussian FederationДальневосточный окружной медицинский центр ФМБА РоссииРоссияFar East Medical Center FMBARussian Federation201928092019031823Copyright © Фомичева Т.Д., Скурихина Ю.Е., Сотниченко С.А., Грибань П.А., Федорец В.В., Тимошенко М.В., Айвазян Р.Р., 20192019Фомичева Т.Д., Скурихина Ю.Е., Сотниченко С.А., Грибань П.А., Федорец В.В., Тимошенко М.В., Айвазян Р.Р.Fomicheva T.D., Skurikhina Y.E., Sotnichenko S.A., Griban P.A., Fedorets V.V., Tymoshenko M.V., Ayvazian R.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tmj-vgmu.ru/jour/article/view/319

Проанализированы данные литературы, касающиеся проблемы инфицирования и циркуляции штаммов Acinetobacter baumannii в госпитальных условиях, рассмотрены вопросы формирования резистентности к антибиотикам, обеспеченность факторами инвазии и «кворум-сенсинга», что позволяет им выдерживать значительные изменения внешних условий, такие как высушивание и обработку моющими средствами. Карбапенемы раньше использовались как препараты выбора для лечения инфекций, вызванных A. baumannii.Однако повышение устойчивости бактерии к этому классу антибактериальных средств, обусловленное β-лактамазами классов B и D делает дальнейшую терапию карбапенемами бессмысленной. Оценена роль процессов образования биологических пленок штаммами A. baumannii, которые способствуют выживанию бактерии в организме человека, и таким образом, служат важным фактором вирулентности. Организация эффективного и динамичного инфекционного контроля в отделениях реанимации и интенсивной терапии считается важным направлением в комплексе мер по повышению качества и своевременности оказания медицинской помощи.

We have analyzed literature data related to contagion issue and Acinetobacter baumannii strains circulation in hospital conditions; we have considered questions of development of resistance to antibiotics, invasion factors and quorum sensing that enables them to bear significant changes of environmental conditions such as drying and cleaning with detergents. Carbapenems have before used as a drug of choice to treat infections caused by A. baumannii. However resistance improvement of bacterium to this group of antibacterial drugs caused by β-lactamases of groups B and D makes further therapy with carbapenems senseless. We have assessed the role of process of formation of biofilms by A. baumannii strains, which facilitate bacteria persistence in human body and serve as important virulence factor. Organizing effective and dynamic infection control in resuscitation and intensive care departments is considered to be an important trend in quality management and healthcare services.

ожоговая болезньграмотрицательные неферментирующие бактерииантибактериальные препаратыAcinetobacter sppburn diseasegram-negative non-fermenting bacteriaantibacterial drugsAcinetobacter sppReferencesАтакишизаде С.А. Чувствительность внутрибольничных штаммов бактерий рода Acinetobacter к некоторым антибиотикам в многопрофильном стационаре г. Баку // Детские инфекции. 2018. № 3. С. 62–63.Atakishizade S.A. Sensitivity of nosocomial strains of bacteria of the genus Acinetobacter to some antibiotics in the multi-profile hospital in Baku // Pediatric Infections. 2018. No. 3. P. 62–63.Воробьева О.Н., Челышева Г.М., Дощицина А.С. [и др.]. Резистентность возбудителей ожоговой болезни к антибиотикам // Современные проблемы медицинской микробиологии. СПб., 2007. С. 165–167.Atakishizade S.A. Sensitivity of nosocomial strains of bacteria of the genus Acinetobacter to some antibiotics in the multi-profile hospital in Baku // Pediatric Infections. 2018. No. 3. P. 62–63.Гончаров А.Е. Эпидемиологические особенности гнойно-септических инфекций, вызванных Acinetobacter baumannii и Preudomonas aeruginosa в ожоговом реанимационном отделении: дис. … канд. мед. наук. СПб., 2005. 151 c.Vorobieva O.N., Chelysheva G.M., Doshchitsina A.S. [et al.]. Resistance of pathogens of burn disease to antibiotics // Modern Problems of Medical Microbiology. Saint Petersburg, 2007. P. 165–167.Горбич Ю.Л., Карпов И.А. Значение адекватной эмпирической антибактериальной терапии при нозокомиальных инфекциях, вызванных Acinetobacter baumannii // Клиническая микробиология и антимикробная химиотерапия. 2012. Т. 14, № 1. С. 67–73.Vorobieva O.N., Chelysheva G.M., Doshchitsina A.S. [et al.]. Resistance of pathogens of burn disease to antibiotics // Modern Problems of Medical Microbiology. Saint Petersburg, 2007. P. 165–167.Гординская Н.А. Сабирова Е.В., Абрамова Н.В. Карбапенемрезистентные грамотрицательные бактерии в структуре раневой ожоговой микрофлоры // Медицинский альманах. 2018. № 4. С. 34–37.Goncharov A.E. Epidemiological features of purulent-septic infections caused by Acinetobacter baumannii and Preudomonas aeruginosa in the burn-through intensive care unit: Thesis for the degree of candidate of medical sciences. Saint Petersburg, 2005. 151 p.Жилина С.В., Миронов А.Ю., Поликарпова С.В. Ацинетобактерии при инфекциях кожи и мягких тканей // Курский научно-практический вестник «Человек и его здоровье». 2007. № 4. С. 45–56.Goncharov A.E. Epidemiological features of purulent-septic infections caused by Acinetobacter baumannii and Preudomonas aeruginosa in the burn-through intensive care unit: Thesis for the degree of candidate of medical sciences. Saint Petersburg, 2005. 151 p.Зубков М.Н. Неферментирующие бактерии Acinetobacter spp.: таксономия и классификация, характеристика, клиническое значение, идентификация, антибиотикорезистентность // Инфекции и антимикробная терапия. 2003. № 2. С. 18–26.Gorbich Yu.L., Karpov I.A. The value of adequate empirical antibacterial therapy for nosocomial infections caused by Acinetobacter baumannii // Clin. Microbiol. Antimicrob. Chemother. 2012. Vol. 14, No. 1. P. 67–73.Крылов К.М, Яфаев Р.Х., Демаков В.А. [и др.]. Генетическое разнообразие Acinetobacter baumannii в отделении ожоговой реанимации // Журнал микробиологии, эпидемиологии и иммунологии. 2006. № 2 . С. 25–30.Gorbich Yu.L., Karpov I.A. The value of adequate empirical antibacterial therapy for nosocomial infections caused by Acinetobacter baumannii // Clin. Microbiol. Antimicrob. Chemother. 2012. Vol. 14, No. 1. P. 67–73.Присакарь В.И., Бердеу И.С., Спэтару Д.Ю. Результаты оценки микробной антибиотикорезистентности в условиях республики Молдова // Медицинский альманах. 2018. № 4. С. 31–34.Gordinskaya N.A. Sabirova E.V., Abramova N.V. Karbapenemresistant gram-negative bacteria in the structure of wound burn microflora // Medical Almanac. 2018. No. 4. P. 34–37.Сатосова Н.В. Эпидемиология и профилактика инфекций кровотока в отделении ожоговой реанимации и интенсивной терапии: дис. … канд. мед. наук. СПб., 2012. 144 с.Gordinskaya N.A. Sabirova E.V., Abramova N.V. Karbapenemresistant gram-negative bacteria in the structure of wound burn microflora // Medical Almanac. 2018. No. 4. P. 34–37.Сатосова Н.В., Крылов К.М., Зуева Л.П. [и др.]. Результаты эпидемиологического наблюдения за инфекциями кровотока в отделении реанимации и интенсивной терапии для пострадавших с тяжелой термической травмой // Вестник гематологии. 2010. Т. VI, № 1. С. 61.Zhilina S.V., Mironov A.Yu., Polikarpova S.V. Acinetobacter in infections of the skin and soft tissues // Kursk Scientific and Practical Journal “Man and His Health”. 2007. No. 4. P. 45–56.Скурихина Ю.Е. Ибрагимова Т.Д., Скурихина Л.А. [и др.]. Молекулярно-эпидемиологический анализ штаммов Acinetobacter baumannii, выделенных у пациентов с ожоговой травмой // Современные технологии в медицине. 2016. Т. 8, № 1. С. 134–139.Zhilina S.V., Mironov A.Yu., Polikarpova S.V. Acinetobacter in infections of the skin and soft tissues // Kursk Scientific and Practical Journal “Man and His Health”. 2007. No. 4. P. 45–56.Скурихина Ю.Е. Прушинский А.П., Завалина Д.Е. Распространенность гнойно-септических инфекций в отделениях детского многопрофильного стационара // Дальневосточный журнал инфекционной патологии. 2017. № 32. С. 58–67.Zubkov M.N. Non-fermenting bacteria Acinetobacter spp.: Taxonomy and classification, characterization, clinical significance, identification, antibiotic resistance // Infectsii i antimikrobnaya terapiya. 2003. No. 2. P. 18–26.Скурихина Ю.Е., Туркутюков В.Б. Микробиологические особенности неферментирующих грамотрицательных бактерий и их влияние на развитие эпидемического процесса инфекций, связанных с оказанием медицинский помощи // Тихоокеанский медицинский журнал. 2016. № 3, прил. С. 111.Zubkov M.N. Non-fermenting bacteria Acinetobacter spp.: Taxonomy and classification, characterization, clinical significance, identification, antibiotic resistance // Infectsii i antimikrobnaya terapiya. 2003. No. 2. P. 18–26.Тапальский Д.В., Бонда Н.А. Acinetobacter baumannii: распространенность, спектр и динамика антибиотикорезистентности, чувствительность к комбинациям антибиотиков // Журнал Гродненского государственного медицинского университета. 2018. Т. 16, № 3. С. 286–291.Krylov KM, Yafaev R.Kh., Demakov V.A. [et al.]. Genetic diversity of Acinetobacter baumannii in the department of burns resuscitation // Journal of Microbiology, Epidemiology and Immunology. 2006. No. 2. P. 25–30.Тарасов А.Е. Иммунологические аспекты ожоговой болезни в клинике и эксперименте: дис. … канд. мед. наук. Владивосток, 2009. 130 с.Krylov KM, Yafaev R.Kh., Demakov V.A. [et al.]. Genetic diversity of Acinetobacter baumannii in the department of burns resuscitation // Journal of Microbiology, Epidemiology and Immunology. 2006. No. 2. P. 25–30.Тец В.В., Заславская Н.В. Эффективность действия антибиотиков на бактерии в биопленках // Журн. микробиол., эпидемиол. и иммунобиол. 2005. № 5. С. 24–26.Prisakar V.I., Berdeu I.S., Spataru D.Yu. The results of the evaluation of microbial antibiotic resistance in the conditions of the Republic of Moldova // Medical Almanac. 2018. No. 4. P. 31–34.Туркутюков В.Б., Ибрагимова Т.Д., Шмагунова Е.В. Этиология гнойно-септических осложнений при ожоговой травме и мониторинг чувствительности микроорганизмов к антибиотикам // Журн. микробиол., эпидемиол. и иммунобиол. 2014. № 2. С. 129.Prisakar V.I., Berdeu I.S., Spataru D.Yu. The results of the evaluation of microbial antibiotic resistance in the conditions of the Republic of Moldova // Medical Almanac. 2018. No. 4. P. 31–34.Фомичева Т.Д., Туркутюков В.Б., Сотниченко С.А. [и др.]. Микробиологический мониторинг в системе эпидемиологического надзора за гнойно-септическими инфекциями при ожоговой травме // Тихоокеанский медицинский журнал, 2018. № 3. С. 72–74.Satosova N.V. Epidemiology and prevention of blood flow infections in the department of burn resuscitation and intensive therapy: Thesis for the degree of candidate of medical sciences. Saint Petersburg, 2012. 144 p.Шлык И.В., Сатосова Н.В., Крылов К.М. [и др.]. Эпидемиологический мониторинг в отделении ожоговой реанимации // Инфекции в хирургии. 2008. Т. 6, № 3. С. 23–27.Satosova N.V. Epidemiology and prevention of blood flow infections in the department of burn resuscitation and intensive therapy: Thesis for the degree of candidate of medical sciences. Saint Petersburg, 2012. 144 p.Acosta J., Merino M., Viedma E. Multidrug-resistant Acinetobacter baumanii harboring OXA-24 Carbapenemase, Spain // Emerg. Infect. Dis. 2011. Vol. 17, No. 6. P.1064–1067.Satosova N.V., Krylov K.M., Zueva L.P. [et al.]. The results of epidemiological monitoring of bloodstream infections in the intensive care unit and intensive care for victims with severe thermal injury // Hematology Bulletin. 2010. Vol. VI, No. 1. P. 61.Al Atrouni A., Hamze, M., Jisr, T. [et al.]. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon // Int. J. Infect. Dis. 2016. Vol. 52. P. 29–36.Satosova N.V., Krylov K.M., Zueva L.P. [et al.]. The results of epidemiological monitoring of bloodstream infections in the intensive care unit and intensive care for victims with severe thermal injury // Hematology Bulletin. 2010. Vol. VI, No. 1. P. 61.Al-Agamy M.H., Jeannot K., El-Mahdy T.S. [et al.]. First detection of ges-5 carbapenemase-producing Acinetobacter baumannii isolate // Microb. Drug Resist. 2016. doi: 10.1089/mdr.2016.0152Skurikhina Yu.E., Ibragimova T.D., Skurikhina L.A. [et al.]. Molecular epidemiological analysis of Acinetobacter baumannii strains isolated from patients with a burn injury // Modern Technologies in Medicine. 2016. Vol. 8. No. 1. P. 134–139.Aly M.M., Abu Alsoud N.M., Elrobh M.S. [et al.]. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia // Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35. P. 1759–1766.Skurikhina Yu.E., Ibragimova T.D., Skurikhina L.A. [et al.]. Molecular epidemiological analysis of Acinetobacter baumannii strains isolated from patients with a burn injury // Modern Technologies in Medicine. 2016. Vol. 8. No. 1. P. 134–139.Babik J., Bodnarova L., Sopko K. [et al.]. Acinetobacter – serious danger for burn patients // Acta Chir. Plast. 2008. Vol. 50, No. 1. P. 27–32.Skurikhina Yu.E. Prushinsky A.P., Zavalina D.E. The prevalence of purulent-septic infections in the departments of children's multidisciplinary hospital // Far Eastern Journal of Infectious Pathology. 2017. No. 32. P. 58–67.Bahador A., Farshadzadeh Z., Raoofian R. [et al.]. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: Analysis of genotype, antimicrobial susceptibility, and biofilm formation // Annals of Clinical Microbiology and Antimicrobials. 2018. Vol. 17, No. 1. P. 24.Skurikhina Yu.E. Prushinsky A.P., Zavalina D.E. The prevalence of purulent-septic infections in the departments of children's multidisciplinary hospital // Far Eastern Journal of Infectious Pathology. 2017. No. 32. P. 58–67.Bassetti M., Righi E., Esposito S. [et al.]. Drug treatment for multidrug-resistant Acinetobacter baumannii infections // Future Microbiol. 2008. Vol. 3, No. 6. P. 649–660.Skurikhina Yu.E., Turkutyukov V.B. Microbiological features of non-fermentative gram-negative bacteria and their influence on the development of the epidemic process of infections associated with the provision of medical care // Pacific Medical Journal. 2016. No. 3, Suppl. P. 111Brahmi N., Biel Y., Kouraichi A. [et al.]. Evoluotion of resistance in Acinetobacter baumannii in Tunisian ICU after antibiotic therapy restriction // Crit. Сare. 2005. Vol. 9, Suppl. 1. P. 19.Skurikhina Yu.E., Turkutyukov V.B. Microbiological features of non-fermentative gram-negative bacteria and their influence on the development of the epidemic process of infections associated with the provision of medical care // Pacific Medical Journal. 2016. No. 3, Suppl. P. 111Carvalho K.R., D’Alincourt A., Carvalho-Assef A.P. [et al.]. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii // Mem. Inst. Oswaldo Cruz, Rio de Janeiro. 2011. Vol. 106, No. 4. P. 505–506.Tapalsky D.V., Bonda N.A. Acinetobacter baumannii: prevalence, spectrum and dynamics of antibiotic resistance, sensitivity to combinations of antibiotics // Journal of Grodno State Medical University. 2018. Vol. 16, No. 3. P. 286–291Chang-Ro Lee, Jung Hun Lee, Moonhee Park [et al.]. Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options // Front. Cell. Infect. Microbiol. 2017. Vol. 7. Art. 55.Tapalsky D.V., Bonda N.A. Acinetobacter baumannii: prevalence, spectrum and dynamics of antibiotic resistance, sensitivity to combinations of antibiotics // Journal of Grodno State Medical University. 2018. Vol. 16, No. 3. P. 286–291Chihi, H., Bonnin, R. A., Bourouis, A. [et al.]. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa // J. Glob. Antimicrob. Resist. 2016. Vol. 5. P. 47–50.Tarasov A.E. Immunological aspects of burn disease in the clinic and experiment: Thesis for the degree of candidate of medical sciences. Vladivostok, 2009. 130 p.Church D., Elsayed S., Reid O. [et al.]. Burn wound infections // Clin. Microbiol. Rev. 2006. Vol. 19, No. 2. P. 403–434.Tarasov A.E. Immunological aspects of burn disease in the clinic and experiment: Thesis for the degree of candidate of medical sciences. Vladivostok, 2009. 130 p.Cobrado L., Pinto Silva A., Pina-Vaz C. [et al.]. Effective disinfection of a burn unit after two cases of sepsis caused by multi-drugresistant Acinetobacter baumannii // Surg. Infect. 2018. Vol. 19, No. 5. P. 541–543.Tets V.V., Zaslavskaya N.V. The effectiveness of antibiotics on bacteria in biofilms // Journal of Microbiology, Epidemiology and Immunobiology. 2005. No. 5. P. 24–26.Fluit, A. C., Maarten R., Visser A. [et al.]. Molecular detectionon of antimicrobial resistance // Clin. Microbiol. Rev. 2001. Vol. 14, No. 4. P. 836–871.Tets V.V., Zaslavskaya N.V. The effectiveness of antibiotics on bacteria in biofilms // Journal of Microbiology, Epidemiology and Immunobiology. 2005. No. 5. P. 24–26.Frikh M., Abdelhay L., Jalal K. [et al.]. Profile and antibiotic susceptibility of bacteria isolates in burn patients hospitalized in a Moroccan hospital: A cross- sectional study // Wounds: A Compendium of Clinical Research and Practice. 2018. Vol. 30, No. 4. P. 102–107.Turkutyukov V.B., Ibragimova T.D., Shmagunova E.V. Etiology of purulent-septic complications in a burn injury and monitoring the sensitivity of microorganisms to antibiotics // Journal of Microbiology, Epidemiology and Immunobiology. 2014. No. 2. P. 129.Gaddy J. Actis L. Regulation of Acinetobacter baumannii biofilm formation // Future Microbiol. 2009. Vol. 4. P. 273–278.Turkutyukov V.B., Ibragimova T.D., Shmagunova E.V. Etiology of purulent-septic complications in a burn injury and monitoring the sensitivity of microorganisms to antibiotics // Journal of Microbiology, Epidemiology and Immunobiology. 2014. No. 2. P. 129.Mitchell J., Schwaber M., Cosgrove S. [et al.]. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens // Emerg. Infect. Dis. 2004. Vol. 10, No. 1. P. 94–98.Fomicheva T.D., Turkutyukov V.B., Sotnichenko S.A. [et al.]. Microbiological monitoring in the system of epidemiological surveillance of purulent-septic infections with burn injury // Pacific Medical Journal, 2018. No. 3. P. 72–74.Mugnier P.D., Poirel L., Naas T. [et al.]. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii // Emerg. Infect. Dis. 2010. Vol. 16, No. 1. P. 35–40.Fomicheva T.D., Turkutyukov V.B., Sotnichenko S.A. [et al.]. Microbiological monitoring in the system of epidemiological surveillance of purulent-septic infections with burn injury // Pacific Medical Journal, 2018. No. 3. P. 72–74.Munier A., Biardb L., Legrandc M. [et al.]. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit // Int. J. Infect. Dis. 2019. Vol. 79. P. 179–184.Shlyk I.V., Satosova N.V., Krylov K.M. [et al.]. Epidemiological monitoring in the department of burns resuscitation // Infections in Surgery. 2008. Vol. 6, No. 3. P. 23–27.Mussi M.A., Gaddy J.A., Cabruja M. [et al]. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light // J. Bacteriol. 2010. Vol. 192, No. 24. P. 6336–6345.Shlyk I.V., Satosova N.V., Krylov K.M. [et al.]. Epidemiological monitoring in the department of burns resuscitation // Infections in Surgery. 2008. Vol. 6, No. 3. P. 23–27.Nemec A., Krizova L., Maixnerova M. [et al]. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU) // Res. Microbiol. 2011. Vol. 162, No. 4. P. 393–404.Acosta J., Merino M., Viedma E. Multidrug-resistant Acinetobacter baumanii harboring OXA-24 Carbapenemase, Spain // Emerg. Infect. Dis. 2011. Vol. 17, No. 6. P.1064–1067.Nishio H., Komatsu M., Shibata N. [et al.]. Metallo-β-lactamaseproducing gram-negative bacilli: Laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan // J. Clinic. Microbiol. 2004. Vol. 42, No. 11. P. 5256–5263.Acosta J., Merino M., Viedma E. Multidrug-resistant Acinetobacter baumanii harboring OXA-24 Carbapenemase, Spain // Emerg. Infect. Dis. 2011. Vol. 17, No. 6. P.1064–1067.Seward R.J. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. // Clin. Microbiol. Infect. 1999. Vol. 5, No. 6. P. 308–318.Al Atrouni A., Hamze, M., Jisr, T. [et al.]. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon // Int. J. Infect. Dis. 2016. Vol. 52. P. 29–36.Shaykh Baygloo N., Bouzari M., Rahimi F. [et al.]. Identification of genomic species of Acinetobacter isolated from burns of ICU patients // Arch. Iran Med. 2015. Vol. 18, No. 10. P. 638–642.Al Atrouni A., Hamze, M., Jisr, T. [et al.]. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon // Int. J. Infect. Dis. 2016. Vol. 52. P. 29–36.Tekin R., Dal T., Bozkurt F. [et al]. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii // J. Burn. Care Res. 2014. Vol. 35, No. 1. P. 73–80.Al-Agamy M.H., Jeannot K., El-Mahdy T.S. [et al.]. First detection of ges-5 carbapenemase-producing Acinetobacter baumannii isolate // Microb. Drug Resist. 2016. doi: 10.1089/mdr.2016.0152Tomaras A., Dorsey C., Edelmann R. [et al.]. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system // Microbiology. 2003. Vol. 149. P. 3473–3484.Al-Agamy M.H., Jeannot K., El-Mahdy T.S. [et al.]. First detection of ges-5 carbapenemase-producing Acinetobacter baumannii isolate // Microb. Drug Resist. 2016. doi: 10.1089/mdr.2016.0152Van Looveren M., Goosens H. Antimicrobial resistance of Acinetobacter spp. in Europe // Clin. Microbiol. Infect. 2004. Vol. 10. P. 684–704.Aly M.M., Abu Alsoud N.M., Elrobh M.S. [et al.]. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia // Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35. P. 1759–1766.Aly M.M., Abu Alsoud N.M., Elrobh M.S. [et al.]. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia // Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35. P. 1759–1766.Aly M.M., Abu Alsoud N.M., Elrobh M.S. [et al.]. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia // Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35. P. 1759–1766.Babik J., Bodnarova L., Sopko K. [et al.]. Acinetobacter – serious danger for burn patients // Acta Chir. Plast. 2008. Vol. 50, No. 1. P. 27–32.Babik J., Bodnarova L., Sopko K. [et al.]. Acinetobacter – serious danger for burn patients // Acta Chir. Plast. 2008. Vol. 50, No. 1. P. 27–32.Babik J., Bodnarova L., Sopko K. [et al.]. Acinetobacter – serious danger for burn patients // Acta Chir. Plast. 2008. Vol. 50, No. 1. P. 27–32.Babik J., Bodnarova L., Sopko K. [et al.]. Acinetobacter – serious danger for burn patients // Acta Chir. Plast. 2008. Vol. 50, No. 1. P. 27–32.Bahador A., Farshadzadeh Z., Raoofian R. [et al.]. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: Analysis of genotype, antimicrobial susceptibility, and biofilm formation // Annals of Clinical Microbiology and Antimicrobials. 2018. Vol. 17, No. 1. P. 24.Bahador A., Farshadzadeh Z., Raoofian R. [et al.]. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: Analysis of genotype, antimicrobial susceptibility, and biofilm formation // Annals of Clinical Microbiology and Antimicrobials. 2018. Vol. 17, No. 1. P. 24.Bahador A., Farshadzadeh Z., Raoofian R. [et al.]. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: Analysis of genotype, antimicrobial susceptibility, and biofilm formation // Annals of Clinical Microbiology and Antimicrobials. 2018. Vol. 17, No. 1. P. 24.Bahador A., Farshadzadeh Z., Raoofian R. [et al.]. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: Analysis of genotype, antimicrobial susceptibility, and biofilm formation // Annals of Clinical Microbiology and Antimicrobials. 2018. Vol. 17, No. 1. P. 24.Bassetti M., Righi E., Esposito S. [et al.]. Drug treatment for multidrug-resistant Acinetobacter baumannii infections // Future Microbiol. 2008. Vol. 3, No. 6. P. 649–660.Bassetti M., Righi E., Esposito S. [et al.]. Drug treatment for multidrug-resistant Acinetobacter baumannii infections // Future Microbiol. 2008. Vol. 3, No. 6. P. 649–660.Bassetti M., Righi E., Esposito S. [et al.]. Drug treatment for multidrug-resistant Acinetobacter baumannii infections // Future Microbiol. 2008. Vol. 3, No. 6. P. 649–660.Bassetti M., Righi E., Esposito S. [et al.]. Drug treatment for multidrug-resistant Acinetobacter baumannii infections // Future Microbiol. 2008. Vol. 3, No. 6. P. 649–660.Brahmi N., Biel Y., Kouraichi A. [et al.]. Evoluotion of resistance in Acinetobacter baumannii in Tunisian ICU after antibiotic therapy restriction // Crit. Сare. 2005. Vol. 9, Suppl. 1. P. 19.Brahmi N., Biel Y., Kouraichi A. [et al.]. Evoluotion of resistance in Acinetobacter baumannii in Tunisian ICU after antibiotic therapy restriction // Crit. Сare. 2005. Vol. 9, Suppl. 1. P. 19.Brahmi N., Biel Y., Kouraichi A. [et al.]. Evoluotion of resistance in Acinetobacter baumannii in Tunisian ICU after antibiotic therapy restriction // Crit. Сare. 2005. Vol. 9, Suppl. 1. P. 19.Brahmi N., Biel Y., Kouraichi A. [et al.]. Evoluotion of resistance in Acinetobacter baumannii in Tunisian ICU after antibiotic therapy restriction // Crit. Сare. 2005. Vol. 9, Suppl. 1. P. 19.Carvalho K.R., D’Alincourt A., Carvalho-Assef A.P. [et al.]. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii // Mem. Inst. Oswaldo Cruz, Rio de Janeiro. 2011. Vol. 106, No. 4. P. 505–506.Carvalho K.R., D’Alincourt A., Carvalho-Assef A.P. [et al.]. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii // Mem. Inst. Oswaldo Cruz, Rio de Janeiro. 2011. Vol. 106, No. 4. P. 505–506.Carvalho K.R., D’Alincourt A., Carvalho-Assef A.P. [et al.]. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii // Mem. Inst. Oswaldo Cruz, Rio de Janeiro. 2011. Vol. 106, No. 4. P. 505–506.Carvalho K.R., D’Alincourt A., Carvalho-Assef A.P. [et al.]. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii // Mem. Inst. Oswaldo Cruz, Rio de Janeiro. 2011. Vol. 106, No. 4. P. 505–506.Chang-Ro Lee, Jung Hun Lee, Moonhee Park [et al.]. Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options // Front. Cell. Infect. Microbiol. 2017. Vol. 7. Art. 55.Chang-Ro Lee, Jung Hun Lee, Moonhee Park [et al.]. Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options // Front. Cell. Infect. Microbiol. 2017. Vol. 7. Art. 55.Chang-Ro Lee, Jung Hun Lee, Moonhee Park [et al.]. Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options // Front. Cell. Infect. Microbiol. 2017. Vol. 7. Art. 55.Chang-Ro Lee, Jung Hun Lee, Moonhee Park [et al.]. Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options // Front. Cell. Infect. Microbiol. 2017. Vol. 7. Art. 55.Chihi, H., Bonnin, R. A., Bourouis, A. [et al.]. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa // J. Glob. Antimicrob. Resist. 2016. Vol. 5. P. 47–50.Chihi, H., Bonnin, R. A., Bourouis, A. [et al.]. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa // J. Glob. Antimicrob. Resist. 2016. Vol. 5. P. 47–50.Chihi, H., Bonnin, R. A., Bourouis, A. [et al.]. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa // J. Glob. Antimicrob. Resist. 2016. Vol. 5. P. 47–50.Chihi, H., Bonnin, R. A., Bourouis, A. [et al.]. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa // J. Glob. Antimicrob. Resist. 2016. Vol. 5. P. 47–50.Church D., Elsayed S., Reid O. [et al.]. Burn wound infections // Clin. Microbiol. Rev. 2006. Vol. 19, No. 2. P. 403–434.Church D., Elsayed S., Reid O. [et al.]. Burn wound infections // Clin. Microbiol. Rev. 2006. Vol. 19, No. 2. P. 403–434.Church D., Elsayed S., Reid O. [et al.]. Burn wound infections // Clin. Microbiol. Rev. 2006. Vol. 19, No. 2. P. 403–434.Church D., Elsayed S., Reid O. [et al.]. Burn wound infections // Clin. Microbiol. Rev. 2006. Vol. 19, No. 2. P. 403–434.Cobrado L., Pinto Silva A., Pina-Vaz C. [et al.]. Effective disinfection of a burn unit after two cases of sepsis caused by multi-drugresistant Acinetobacter baumannii // Surg. Infect. 2018. Vol. 19, No. 5. P. 541–543.Cobrado L., Pinto Silva A., Pina-Vaz C. [et al.]. Effective disinfection of a burn unit after two cases of sepsis caused by multi-drugresistant Acinetobacter baumannii // Surg. Infect. 2018. Vol. 19, No. 5. P. 541–543.Cobrado L., Pinto Silva A., Pina-Vaz C. [et al.]. Effective disinfection of a burn unit after two cases of sepsis caused by multi-drugresistant Acinetobacter baumannii // Surg. Infect. 2018. Vol. 19, No. 5. P. 541–543.Cobrado L., Pinto Silva A., Pina-Vaz C. [et al.]. Effective disinfection of a burn unit after two cases of sepsis caused by multi-drugresistant Acinetobacter baumannii // Surg. Infect. 2018. Vol. 19, No. 5. P. 541–543.Fluit, A. C., Maarten R., Visser A. [et al.]. Molecular detectionon of antimicrobial resistance // Clin. Microbiol. Rev. 2001. Vol. 14, No. 4. P. 836–871.Fluit, A. C., Maarten R., Visser A. [et al.]. Molecular detectionon of antimicrobial resistance // Clin. Microbiol. Rev. 2001. Vol. 14, No. 4. P. 836–871.Fluit, A. C., Maarten R., Visser A. [et al.]. Molecular detectionon of antimicrobial resistance // Clin. Microbiol. Rev. 2001. Vol. 14, No. 4. P. 836–871.Fluit, A. C., Maarten R., Visser A. [et al.]. Molecular detectionon of antimicrobial resistance // Clin. Microbiol. Rev. 2001. Vol. 14, No. 4. P. 836–871.Frikh M., Abdelhay L., Jalal K. [et al.]. Profile and antibiotic susceptibility of bacteria isolates in burn patients hospitalized in a Moroccan hospital: A cross-sectional study // Wounds: A Compendium of Clinical Research and Practice. 2018. Vol. 30, No. 4. P. 102–107.Frikh M., Abdelhay L., Jalal K. [et al.]. Profile and antibiotic susceptibility of bacteria isolates in burn patients hospitalized in a Moroccan hospital: A cross-sectional study // Wounds: A Compendium of Clinical Research and Practice. 2018. Vol. 30, No. 4. P. 102–107.Frikh M., Abdelhay L., Jalal K. [et al.]. Profile and antibiotic susceptibility of bacteria isolates in burn patients hospitalized in a Moroccan hospital: A cross-sectional study // Wounds: A Compendium of Clinical Research and Practice. 2018. Vol. 30, No. 4. P. 102–107.Frikh M., Abdelhay L., Jalal K. [et al.]. Profile and antibiotic susceptibility of bacteria isolates in burn patients hospitalized in a Moroccan hospital: A cross-sectional study // Wounds: A Compendium of Clinical Research and Practice. 2018. Vol. 30, No. 4. P. 102–107.Gaddy J. Actis L. Regulation of Acinetobacter baumannii biofilm formation // Future Microbiol. 2009. Vol. 4. P. 273–278.Gaddy J. Actis L. Regulation of Acinetobacter baumannii biofilm formation // Future Microbiol. 2009. Vol. 4. P. 273–278.Gaddy J. Actis L. Regulation of Acinetobacter baumannii biofilm formation // Future Microbiol. 2009. Vol. 4. P. 273–278.Gaddy J. Actis L. Regulation of Acinetobacter baumannii biofilm formation // Future Microbiol. 2009. Vol. 4. P. 273–278.Mitchell J., Schwaber M., Cosgrove S. [et al.]. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens // Emerg. Infect. Dis. 2004. Vol. 10, No. 1. P. 94–98.Mitchell J., Schwaber M., Cosgrove S. [et al.]. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens // Emerg. Infect. Dis. 2004. Vol. 10, No. 1. P. 94–98.Mitchell J., Schwaber M., Cosgrove S. [et al.]. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens // Emerg. Infect. Dis. 2004. Vol. 10, No. 1. P. 94–98.Mitchell J., Schwaber M., Cosgrove S. [et al.]. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens // Emerg. Infect. Dis. 2004. Vol. 10, No. 1. P. 94–98.Mugnier P.D., Poirel L., Naas T. [et al.]. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii // Emerg. Infect. Dis. 2010. Vol. 16, No. 1. P. 35–40.Mugnier P.D., Poirel L., Naas T. [et al.]. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii // Emerg. Infect. Dis. 2010. Vol. 16, No. 1. P. 35–40.Mugnier P.D., Poirel L., Naas T. [et al.]. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii // Emerg. Infect. Dis. 2010. Vol. 16, No. 1. P. 35–40.Mugnier P.D., Poirel L., Naas T. [et al.]. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii // Emerg. Infect. Dis. 2010. Vol. 16, No. 1. P. 35–40.Munier A., Biardb L., Legrandc M. [et al.]. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit // Int. J. Infect. Dis. 2019. Vol. 79. P. 179–184.Munier A., Biardb L., Legrandc M. [et al.]. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit // Int. J. Infect. Dis. 2019. Vol. 79. P. 179–184.Munier A., Biardb L., Legrandc M. [et al.]. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit // Int. J. Infect. Dis. 2019. Vol. 79. P. 179–184.Munier A., Biardb L., Legrandc M. [et al.]. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit // Int. J. Infect. Dis. 2019. Vol. 79. P. 179–184.Mussi M.A., Gaddy J.A., Cabruja M. [et al]. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light // J. Bacteriol. 2010. Vol. 192, No. 24. P. 6336–6345.Mussi M.A., Gaddy J.A., Cabruja M. [et al]. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light // J. Bacteriol. 2010. Vol. 192, No. 24. P. 6336–6345.Mussi M.A., Gaddy J.A., Cabruja M. [et al]. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light // J. Bacteriol. 2010. Vol. 192, No. 24. P. 6336–6345.Mussi M.A., Gaddy J.A., Cabruja M. [et al]. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light // J. Bacteriol. 2010. Vol. 192, No. 24. P. 6336–6345.Nemec A., Krizova L., Maixnerova M. [et al]. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU) // Res. Microbiol. 2011. Vol. 162, No. 4. P. 393–404.Nemec A., Krizova L., Maixnerova M. [et al]. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU) // Res. Microbiol. 2011. Vol. 162, No. 4. P. 393–404.Nemec A., Krizova L., Maixnerova M. [et al]. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU) // Res. Microbiol. 2011. Vol. 162, No. 4. P. 393–404.Nemec A., Krizova L., Maixnerova M. [et al]. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU) // Res. Microbiol. 2011. Vol. 162, No. 4. P. 393–404.Nishio H., Komatsu M., Shibata N. [et al.]. Metallo-β-lactamaseproducing gram-negative bacilli: Laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan // J. Clinic. Microbiol. 2004. Vol. 42, No. 11. P. 5256–5263.Nishio H., Komatsu M., Shibata N. [et al.]. Metallo-β-lactamaseproducing gram-negative bacilli: Laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan // J. Clinic. Microbiol. 2004. Vol. 42, No. 11. P. 5256–5263.Nishio H., Komatsu M., Shibata N. [et al.]. Metallo-β-lactamaseproducing gram-negative bacilli: Laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan // J. Clinic. Microbiol. 2004. Vol. 42, No. 11. P. 5256–5263.Nishio H., Komatsu M., Shibata N. [et al.]. Metallo-β-lactamaseproducing gram-negative bacilli: Laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan // J. Clinic. Microbiol. 2004. Vol. 42, No. 11. P. 5256–5263.Seward R.J. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. // Clin. Microbiol. Infect. 1999. Vol. 5, No. 6. P. 308–318.Seward R.J. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. // Clin. Microbiol. Infect. 1999. Vol. 5, No. 6. P. 308–318.Seward R.J. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. // Clin. Microbiol. Infect. 1999. Vol. 5, No. 6. P. 308–318.Seward R.J. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. // Clin. Microbiol. Infect. 1999. Vol. 5, No. 6. P. 308–318.Shaykh Baygloo N., Bouzari M., Rahimi F. [et al.]. Identification of genomic species of Acinetobacter isolated from burns of ICU patients // Arch. Iran Med. 2015. Vol. 18, No. 10. P. 638–642.Shaykh Baygloo N., Bouzari M., Rahimi F. [et al.]. Identification of genomic species of Acinetobacter isolated from burns of ICU patients // Arch. Iran Med. 2015. Vol. 18, No. 10. P. 638–642.Shaykh Baygloo N., Bouzari M., Rahimi F. [et al.]. Identification of genomic species of Acinetobacter isolated from burns of ICU patients // Arch. Iran Med. 2015. Vol. 18, No. 10. P. 638–642.Shaykh Baygloo N., Bouzari M., Rahimi F. [et al.]. Identification of genomic species of Acinetobacter isolated from burns of ICU patients // Arch. Iran Med. 2015. Vol. 18, No. 10. P. 638–642.Tekin R., Dal T., Bozkurt F. [et al]. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii // J. Burn. Care Res. 2014. Vol. 35, No. 1. P. 73–80.Tekin R., Dal T., Bozkurt F. [et al]. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii // J. Burn. Care Res. 2014. Vol. 35, No. 1. P. 73–80.Tekin R., Dal T., Bozkurt F. [et al]. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii // J. Burn. Care Res. 2014. Vol. 35, No. 1. P. 73–80.Tekin R., Dal T., Bozkurt F. [et al]. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii // J. Burn. Care Res. 2014. Vol. 35, No. 1. P. 73–80.Tomaras A., Dorsey C., Edelmann R. [et al.]. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system // Microbiology. 2003. Vol. 149. P. 3473–3484.Tomaras A., Dorsey C., Edelmann R. [et al.]. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system // Microbiology. 2003. Vol. 149. P. 3473–3484.Tomaras A., Dorsey C., Edelmann R. [et al.]. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system // Microbiology. 2003. Vol. 149. P. 3473–3484.Tomaras A., Dorsey C., Edelmann R. [et al.]. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system // Microbiology. 2003. Vol. 149. P. 3473–3484.Van Looveren M., Goosens H. Antimicrobial resistance of Acinetobacter spp. in Europe // Clin. Microbiol. Infect. 2004. Vol. 10. P. 684–704.Van Looveren M., Goosens H. Antimicrobial resistance of Acinetobacter spp. in Europe // Clin. Microbiol. Infect. 2004. Vol. 10. P. 684–704.Van Looveren M., Goosens H. Antimicrobial resistance of Acinetobacter spp. in Europe // Clin. Microbiol. Infect. 2004. Vol. 10. P. 684–704.Van Looveren M., Goosens H. Antimicrobial resistance of Acinetobacter spp. in Europe // Clin. Microbiol. Infect. 2004. Vol. 10. P. 684–704.

The authors declare that there are no conflicts of interest present.